Avail Clinical Research Announces Smoking Cessation Research Studies in DeLand, Florida

Avail Clinical Research conducts Clinical Research Studies in DeLand, FL. Call 386-310-1334 to find out more about participating in research studies. End Quote

Orlando, FL (1888PressRelease) March 20, 2011 - DeLand, Florida- Avail Clinical Research, a privately owned research facility, founded in 1988 in DeLand, Florida, announces the launch of several research studies to test investigational treatment options for those already diagnosed with Smoking Cessation. "Through clinical research studies, we can strive to significantly build on data previously conducted on those currently diagnosed with smoking cessation," says Bruce G. Rankin, DO, CPI, the Medical Director and Principal Investigator at Avail Clinical Research since 1999. "Treatments for smoking cessation are one of the research studies we are pleased to continue with at Avail Clinical Research. Our systemic evaluation clinical research trials are designed specifically to test the safety and efficacy of treatments for humans."

The research studies will enroll those already diagnosed with smoking cessation. Avail Clinical Research will take volunteers who:

- have a really strong desire to quit smoking (study is a year long and comes with counseling to help people quit permanently)
- willing to use a tobacco alternative (study offers a random selection of SNUS or lozenges as the tobacco alternative)
- are 21 or older
- currently smoke more than 10 cigarettes a day
- are not obese
- do not have any of the following: Diabetes, HIV, Hep B, Hep C

Avail Clinical Research conducts clinical trials for diabetes, COPD, gout, OsteoArthritis and other conditions. Located in DeLand, Florida, near Orlando and Daytona Beach. Participation can include medical care.

###

space

Other Related Press Releases